Improper administration, such as using unsterile needles, can lead to infections or other complications, amplifying the risks associated with this peptide
From a methodological standpoint, safety and monitoring were not separate from efficacy-they were intertwined
Additionally, if you're experiencing symptoms such as persistent abdominal pain, blood in your stools, excessive weight loss, or any symptoms that significantly interfere with your day-to-day activities, it's important to speak with your prescribing physician, as you may need to temporarily reduce your GLP-1 dose and be screened for more serious causes of your symptoms, such as IBD or colorectal cancer
The study authors couldnt determine whether the medication itself caused these outcomes, or whether theyre attributable to the underlying health conditions of the women taking it
The SELECT trial demonstrated that semaglutide 2.4 mg weekly reduced cardiovascular events in adults with established cardiovascular disease and either overweight or obesity